Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.70 |
| ▸ | TSHR | P16473 | 6/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | ESR1 | P03372 | 3/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.58 |
| ▸ | KDR | P35968 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.55 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL130761 | 0.92 | LMNA (1.00) | LMNATDP1TSHRALDH1A1ESR1 | |
| SCHEMBL7181498 | 0.92 | LMNA (1.00) | LMNATDP1TSHRALDH1A1ESR1 | |
| SCHEMBL137486 | 0.91 | TDP1 (0.83) | LMNATDP1TSHRALDH1A1ESR1 | |
| Butane SCHEMBL2548386 | 0.90 | LMNA (0.76) | LMNATDP1TSHRALDH1A1ESR1 | |
| Methane SCHEMBL28760616 | 0.90 | LMNA (0.96) | LMNATDP1TSHRALDH1A1ESR1 | |
| SCHEMBL28387455 | 0.90 | LMNA (0.96) | LMNATDP1TSHRALDH1A1ESR1 | |
| Methyl Alcohol SCHEMBL28069166 | 0.90 | LMNA (0.96) | LMNATDP1TSHRALDH1A1ESR1 | |
| SCHEMBL30886680 | 0.90 | LMNA (0.96) | LMNATDP1TSHRALDH1A1ESR1 | |
| SCHEMBL4465574 | 0.90 | LMNA (0.96) | LMNATDP1TSHRALDH1A1ESR1 | |
| Hydrochloric Acid SCHEMBL27605432 | 0.90 | LMNA (0.96) | LMNATDP1TSHRALDH1A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200339765-A1 | Plastic Articles Containing Suspended Photochromic Dye Molecules | 1-MATERIAL INC (CA) | 2020-10-29 | — | — | US | claimed |
| EP-1748969-A1 | METHOD OF ENHANCING THE APPEARANCE OF A SOILED POROUS SURFACE AND MAINTENANCE THEREOF | JohnsonDiversey, Inc. (US) | 2007-02-07 | — | — | EP | claimed |
| US-7071153-B2 | Method of enhancing a soiled porous surface and maintenance thereof | JOHNSONDIVERSEY, INC. (US) | 2006-07-04 | — | — | US | claimed |
| WO-2005110946-A1 | METHOD OF ENHANCING THE APPEARANCE OF A SOILED POROUS SURFACE AND MAINTENANCE THEREOF | JOHNSONDIVERSEY, INC. (US) | 2005-11-24 | — | — | WO | claimed |
| US-20050245420-A1 | METHOD OF ENHANCING A SOILED POROUS SURFACE AND MAINTENANCE THEREOF | JOHNSONDIVERSEY, INC. (US) | 2005-11-03 | — | — | US | claimed |
| EP-0284302-A2 | High solids PSA compounds | BASF Aktiengesellschaft (DE) | 1988-09-28 | — | — | EP | claimed |
| US-4767813-A | High solids PSA Compounds | POLYSAR FINANCIAL SERVICES S.A. (CH) | 1988-08-30 | — | — | US | claimed |
| US-11015028-B2 | Plastic articles containing suspended photochromic dye molecules | ZHEJIANG JINGYI NEW MATERIAL TECHNOLOGY CO., LTD (CN) | 2021-05-25 | — | — | US | disclosed |
| US-20200339765-A1 | Plastic Articles Containing Suspended Photochromic Dye Molecules | 1-MATERIAL INC (CA) | 2020-10-29 | — | — | US | disclosed |
| US-10682361-B2 | Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction | ALLERGAN, INC. (US) | 2020-06-16 | — | — | US | disclosed |
| EP-3656375-A1 | SUSTAINED RELEASE OF BIMATOPROST, BIMATOPROST ANALOGS, PROSTAMIDES AND PROSTAGLANDINS FOR FAT REDUCTION | ALLERGAN, INC. (US) | 2020-05-27 | — | — | EP | disclosed |
| EP-2983663-B1 | SUSTAINED RELEASE OF BIMATOPROST, BIMATOPROST ANALOGS, PROSTAMIDES AND PROSTAGLANDINS FOR FAT REDUCTION | ALLERGAN INC (US) | 2020-01-22 | — | — | EP | disclosed |
| US-20160339039-A1 | SUSTAINED RELEASE BIMATOPROST, BIMATOPROST ANALOGS, PROSTAMIDES AND PROSTAGLANDINS FOR FAT REDUCTION | ALLERGAN INC (US) | 2016-11-24 | — | — | US | disclosed |
| US-5409734-A | Phase separation of a mixture comprising a homogeneous polymeric solution and a liquid suspension of light-polarizing particles | HANKUK GLASS INDUSTRIES, INC. (KR) | 1995-04-25 | — | — | US | disclosed |
| WO-1993014425-A1 | LIGHT-POLARIZING LIQUID SUSPENSION, AND METHOD FOR MAKING THE LIQUID SUSPENSION | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-22 | — | — | WO | disclosed |
| WO-1993014426-A1 | FILM FOR A LIGHT VALVE, AND METHOD FOR MANUFACTURING THE FILM | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-22 | — | — | WO | disclosed |
| EP-0551138-A1 | Film for a light valve, and method for manufacturing the film | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-14 | — | — | EP | disclosed |
| EP-0551137-A1 | Light-polarizing liquid suspension, and method for making the liquid suspension | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-14 | — | — | EP | disclosed |
| EP-0105994-B1 | THERMOPLASTIC INKS FOR DECORATING PURPOSES | Corning Glass Works (US) | 1987-03-25 | — | — | EP | disclosed |
| EP-0105994-A1 | Thermoplastic inks for decorating purposes | Corning Glass Works (US) | 1984-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10682361-B2 | Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction | FABP4, PNLIP, PTGIS | LMNA 2896/4885TDP1 2847/4885TSHR 2910/4885 |
| US-20160339039-A1 | SUSTAINED RELEASE BIMATOPROST, BIMATOPROST ANALOGS, PROSTAMIDES AND PROSTAGLANDINS FOR FAT REDUCTION | FABP4, PNLIP, PTGIS | LMNA 2896/4885TDP1 2847/4885TSHR 2910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.